{"database":"EGA","file_versions":[],"scores":null,"additional":{"omics_type":["Genomics"],"dataset_type":["Illumina HiSeq 2500;ILLUMINA"],"full_dataset_link":["https://ega-archive.org/datasets/EGAD00001004183"],"sample_count":["589"],"description":["EGA dataset EGAD00001004183"],"repository":["EGA"],"title":["Molecular and phenotypic data for patients enrolled in the IMmotion150 trial"],"name_synonyms":["Vasp, VASP, DmelCG15112, ENHANCER OF ATNSI ACTIVITY, Data Set, DMRV, MENA, NDPP1, Uae1, 2310066H07Rik, l(2)02029, Enb, enb, ENA, Ena, GLCNE, IBM2, CG15112, 2018., ENA/VASP, NM"],"description_synonyms":["Adenocarcinoma, immunoglobulin G1, clear cell renal cell adenocarcinoma, Collecting Duct, Care Standards, SU 011248, Transcriptome Profile, Complete Exome, Neoplasms, SU 11248, Benign Neoplasm, Renal Cell Cancers, Gene Expression Profile, Gene, adenocarcinoma of kidney, Profiles, Renal Adenocarcinomas, Tumor, Malignant, Papillary Renal Cell Carcinoma, CCRCC, Medical Specialties, Mutations, Publication., Speciality, Hypernephroid, Adenocarcinoma Of Kidneys, Medical Specialities, Renal Cell Adenocarcinomas, anti-PDL1, Specialities, Sarcomatoid Renal Cell Carcinoma, Sutent, Tecentriq, RCC, Hypernephroid Carcinomas, Whole Transcriptome, Transcriptome Sequencing, Renal Carcinomas, Hypernephroid Carcinoma, disulfide with human monoclonal MDPL3280a kappa-chain, Medical, RG7446, hypernephroma, Grawitz Tumor, average, WES, Complete, Insurance Medicine, Exome Sequencings, Hypernephromas, Malignancy, Profile, Complete Exome Sequencing, MPDL3280A, Whole Transcriptome Sequencing, Collecting Duct Carcinoma, Renal, Signatures, Sequencing, Neoplasias, clear cell renal cell carcinoma, Whole Exome, drugs, Expression Signature, medicine, Clients, Whole, Transcriptomes, Medicine, Malignancies, Renal Collecting Duct Carcinoma, Medicines, Insurance, Sunitinib Malate, Collecting Duct Carcinomas (Kidney), Mvasi, Cancer, Tumors, Grawitz, sunitinibum, Carcinoma, Specialties, Adenocarcinoma Of, Transcriptome, dimer, Malignant Neoplasm, Complete Exome Sequencings, Data Set, Medical Specialty, 5-(5-Fluoro-2-oxo-1, SU11248, Chromophil Renal Cell Carcinoma, Collecting Duct Carcinomas, Expression Profiles, Exome, Renal Cell Carcinomas, Renal Cell Adenocarcinoma, Renal Adenocarcinoma, Adenocarcinoma Of Kidney, Bevacizumab awwb, Client, Renal Cell Carcinoma, Adenocarcinomas, sunitinib, Gene Expression, Chromophobe Renal Cell Carcinoma, Collecting Duct Carcinoma of the Kidney, Medical Speciality, Exome Sequencing, renal cell adenocarcinoma, Clear Cell Renal Cell Carcinoma, Benign, Expression Signatures, Gene Expression Signatures, Avastin, SU-011248, Neoplasm, Specialty, Gene Expression Signature, Nephroid Carcinomas, anti-(human CD antigen CD274) (human monoclonal MDPL3280a heavy chain), Standards of Care, 4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, Expression Profile, Hypernephroma, Transcriptome Profiles, Carcinomas, Complete Transcriptome, kidney adenocarcinoma, Complete Transcriptome Sequencing, RG-7446, Renal Cell, Renal Carcinoma, Kidney, Benign Neoplasms, Cancers, Nephroid, Bevacizumab-awwb, Renal Cell Cancer, Malignant Neoplasms, Papillary, Insurance Medicines, Patient, Gene Expression Profiles, Collecting Duct Carcinoma (Kidney), SU-11248, SU011248, Collecting Duct (Kidney), Whole Exome Sequencing, renal cell carcinoma, Signature, other neoplasm, 2-dihydroindolylidenemethyl)-2, Transcriptome Sequencings, Nephroid Carcinoma, MPDL-3280A, Neoplasia, Care Standard, Clear Cell Renal Carcinoma"],"additional_accession":[]},"is_claimable":false,"name":"ena-DATASET-GNE-29-06-2018-17:19:56:206-1565 - samples","description":"Tumor transcriptome and whole exome sequencing data (matched tumor/normal for somatic mutation calling) along with key phenotypic information are provided for patients enrolled in the phase 2 IMmotion150 trial, assessing efficacy of atezolizumab monotherapy or combination of atezolizumab and bevacizumab versus standard of care (sunitinib) in 1L renal cell carcinoma. This data set accompanies the respective Nature Medicine publication (PMID: 29867230).","dates":{"updated":"2018-07-16 10:51:07"},"accession":"EGAD00001004183","cross_references":{"TAXONOMY":["9606"],"EGA":["EGAC00001000946","EGAS00001002928"]}}